comparemela.com

Latest Breaking News On - Vifor international ag - Page 1 : comparemela.com

Personal Injury Suit Filed Against Makers of Injectafer

U S District Court for the Eastern District of Pennsylvania: Actions Taken on July 12

U S District Court for the Eastern District of Pennsylvania: Actions Taken on July 12
pennrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pennrecord.com Daily Mail and Mail on Sunday newspapers.

Luitpold Pharmaceuticals Sued Over Failure to Warn of Injectafer Risks

U S District Court for the Eastern District of Pennsylvania: Actions Taken on April 19

Merck & Co. Inc. and Merck Sharp & Dohme Corp.: Complaint Against All Defendants ( Filing Fee $ 402 Receipt Number 0313-15064138.), Filed By Joyce Dworsky, George Dworsky. (attachments: # 1 Civil Cover Sheet Civil Cover Sheet, # 2 Certificate Of Service Merck & Co. Inc. /pos, # 3 Certificate Of Service McKesson Corp./pos, #4 Certificate Of Service Merck Sharp And Dohme Corp./Pos, # 5 Case Management Track Form Case Management Track Form, # 6 Designation Form Designation Form)(humphrey, Debra) Case number 2:21-cv-01814 was filed in the U.S. District Court for the Eastern District of Pennsylvania. In Geico Casualty Company: Complaint Against Geico Casualty Company ( Filing Fee $ 402 Receipt Number 0313-15063213.), Filed By Melvin Marshall.(simon, Marc)

Personal Injury Suit Filed Against Makers of Injectafer

Health your username February 10, 2021 A married couple has sued the manufacturers of an iron product known as Injectafer, after one plaintiff allegedly suffered serious injuries and economic losses following two injections. Tuesday’s complaint, filed in the Eastern District of Pennsylvania, explains that Injectafer is an iron replacement medication manufactured by Luitpold Pharmaceuticals, Inc., American Regent, Inc., Daiichi Sankyo, Inc., Daiichi Sankyo US Holdings, Inc., Vifor Pharma Ltd., Vifor Pharma Participations Ltd., Vifor (International) Ag, and Relypsa Inc. The drug is reportedly indicated “for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron, or in adult patients with non-dialysis dependent chronic kidney disease.”  

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.